Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of TAS-102 in Patients with Metastatic Colorectal Cancer; the HGCSG1503 Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results assessing safety and efficacy of TAS-102 in patients with metastatic colorectal cancer, were presented at the 42nd European Society for Medical Oncology Congress.
- 15 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 18 May 2016 New trial record